NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Institute of Health Economics (IHE): IHE Systematic Reviews [Internet].
This STE report examines the safety, screening accuracy, therapeutic efficacy/effectiveness, cost-effectiveness, budget impact, and health system readiness of newborn screening for seven conditions (galactosemia, tyrosinemia type I, homocystinuria, sickle cell anemia, sickle cell/beta-thalassemia, sickle cell/hemoglobin C disease, and severe combined immunodeficiency), contextualized to the Alberta setting.
Preliminary version: HTML in process
- NLM CatalogRelated NLM Catalog Entries
- Regional experience with newborn screening for sickle cell disease, other hemoglobinopathies and G6PD deficiency.[Ann Saudi Med. 2003]Regional experience with newborn screening for sickle cell disease, other hemoglobinopathies and G6PD deficiency.Nasserullah Z, Alshammari A, Abbas MA, Abu-Khamseen Y, Qadri M, Jafer SA, Wabel MA. Ann Saudi Med. 2003 Nov-Dec; 23(6):354-7.
- Newborn screening for sickle cell disease: effect on mortality.[Pediatrics. 1988]Newborn screening for sickle cell disease: effect on mortality.Vichinsky E, Hurst D, Earles A, Kleman K, Lubin B. Pediatrics. 1988 Jun; 81(6):749-55.
- Clinical Utility of Confirmatory Genetic Testing to Differentiate Sickle Cell Trait from Sickle-β(+)-Thalassemia by Newborn Screening.[Int J Neonatal Screen. 2020]Clinical Utility of Confirmatory Genetic Testing to Differentiate Sickle Cell Trait from Sickle-β(+)-Thalassemia by Newborn Screening.Shook LM, Haygood D, Quinn CT. Int J Neonatal Screen. 2020 Mar; 6(1). Epub 2020 Jan 31.
- Review Carrier screening for thalassemia and hemoglobinopathies in Canada.[J Obstet Gynaecol Can. 2008]Review Carrier screening for thalassemia and hemoglobinopathies in Canada.Langlois S, Ford JC, Chitayat D, CCMG PRENATAL DIAGNOSIS COMMITTEE, SOGC GENETICS COMMITTEE. J Obstet Gynaecol Can. 2008 Oct; 30(10):950-959.
- Review Digital Breast Tomosynthesis with Hologic 3D Mammography Selenia Dimensions System for Use in Breast Cancer Screening: A Single Technology Assessment[ 2017]Review Digital Breast Tomosynthesis with Hologic 3D Mammography Selenia Dimensions System for Use in Breast Cancer Screening: A Single Technology AssessmentMovik E, Dalsbø TK, Fagelund BC, Friberg EG, Håheim LL, Skår Å. 2017 Sep 4
- Newborn Blood Spot Screening for Galactosemia, Tyrosinemia Type I, Homocystinuri...Newborn Blood Spot Screening for Galactosemia, Tyrosinemia Type I, Homocystinuria, Sickle Cell Anemia, Sickle Cell/Beta-Thalassemia, Sickle Cell/Hemoglobin C Disease and Severe Combined Immunodeficiency: Costs and Cost Analysis
Your browsing activity is empty.
Activity recording is turned off.
See more...